Alector (ALEC) Operating Expenses (2018 - 2026)
Alector (ALEC) reported Operating Expenses of $26.0 million for Q1 2026, down 46.32% year-over-year from $48.4 million in Q1 2025, and down 43.31% quarter-over-quarter from $45.8 million in Q4 2025.
Alector (ALEC) Operating Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Operating Expenses data on file, last reported at $26.0 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $26.0 million, down 46.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $154.6 million (down 34.0% YoY), and the FY2025 annual result was $177.1 million, down 27.9% from the prior year.
- Operating Expenses retreated to $26.0 million in Q1 2026 per ALEC's latest filing, from $45.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $70.4 million in Q2 2022 and troughed at $26.0 million in Q1 2026.
- A 5-year average of $57.0 million and a median of $60.7 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses rose 20.89% in 2022, then slumped 46.32% in 2026.
- A 5-year view of Operating Expenses shows it stood at $69.9 million in 2022, then retreated by 10.35% to $62.6 million in 2023, then declined by 1.84% to $61.5 million in 2024, then fell by 25.51% to $45.8 million in 2025, then sank by 43.31% to $26.0 million in 2026.
- Business Quant data shows ALEC's Operating Expenses at $26.0 million in Q1 2026, $45.8 million in Q4 2025, and $40.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 25.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.97 Mn |
| Dec 31, 2025 | 45.80 Mn |
| Sep 30, 2025 | 40.87 Mn |
| Jun 30, 2025 | 42.01 Mn |
| Mar 31, 2025 | 48.37 Mn |
| Dec 31, 2024 | 61.49 Mn |
| Sep 30, 2024 | 63.78 Mn |
| Jun 30, 2024 | 60.69 Mn |
| Mar 31, 2024 | 59.60 Mn |
| Dec 31, 2023 | 62.64 Mn |
| Sep 30, 2023 | 59.69 Mn |
| Jun 30, 2023 | 59.80 Mn |
| Mar 31, 2023 | 66.66 Mn |
| Dec 31, 2022 | 69.88 Mn |
| Sep 30, 2022 | 62.60 Mn |
| Jun 30, 2022 | 70.38 Mn |
| Mar 31, 2022 | 68.60 Mn |
| Dec 31, 2021 | 69.72 Mn |
| Sep 30, 2021 | 56.08 Mn |
| Jun 30, 2021 | 61.89 Mn |